Skip to main content
editorial
. 2017 Nov 29;47(6):858–860. doi: 10.4070/kcj.2017.0330

Table 1. A comparison of the KOTRY with the representative ISHLT HTPL registry and a Japanese HTPL registry.

KOTRY (183 patients; Apr. 2014–Dec. 2015) ISHLT (30,503 patients; Jan. 2009–Jun. 2016) Japan (284 patients; Feb. 1999–Jun. 2016)
Number of HTPLs (annually, /year) 131.5 (2014–2015) ≒2,500 33.3 (2010–2015)
Mean donor age (years) 37.6 35.0 NA
Mean recipient age (years) 50.5 55.0 38.1
Male 67.2% 75.0% 74.0%
Underlying diseases (DCM/ICM) 69%/14% 50%/34% 66%/8%
Inotropic support 93% 40% 5% (2010–2015)
ECMO 19% 1% 34% (2010–2015)
Long-term VAD 0% 43% 61% (2010–2015)
One-year survival rate 91.6% 85.0% 98.0%

Values are presented as number or percentage.

DCM = dilated cardiomyopathy; ECMO = extracorporeal membrane oxygenator; HTPL = heart transplantation; ICM = ischemic cardiomyopathy; ISHLT = International Society for Heart and Lung Transplantation; KOTRY = Korean Organ Transplant Registry; NA = not available; VAD = ventricular assist device.